Gene therapy for the treatment of hemophilia B using PINC-formulated plasmid delivered to muscle with electroporation. | Mol Ther;3(4): 574-83, 2001 Apr. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

Gene therapy for the treatment of hemophilia B using PINC-formulated plasmid delivered to muscle with electroporation.

Fewell, J G; MacLaughlin, F; Mehta, V; Gondo, M; Nicol, F; Wilson, E; Smith, L C.

Affiliation

Fewell JG; Valentis, Inc., The Woodlands, Texas 77381, USA.

Mol Ther ; 3(4): 574-83, 2001 Apr.

Article in En | MEDLINE | ID: mdl-11319920

Subject(s)

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Plasmids / Polymers / Genetic Therapy / Hemophilia B / Electroporation / Muscles Type of study: Prognostic_studies Limits: Animals / Humans / Male Language: En Journal: Mol Ther Journal subject: BIOLOGIA MOLECULAR / TERAPEUTICA Year: 2001 Document type: Article Affiliation country:

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Plasmids / Polymers / Genetic Therapy / Hemophilia B / Electroporation / Muscles Type of study: Prognostic_studies Limits: Animals / Humans / Male Language: En Journal: Mol Ther Journal subject: BIOLOGIA MOLECULAR / TERAPEUTICA Year: 2001 Document type: Article Affiliation country: